Page 1 of Clinical Trials for Phosphodiesterase Type 5 Inhibitors, 427 Total Matches
- 1CompletedLast Updated: October 6, 2008Condition(s): Pharmacokinetics of Three PDE5Is; Healthy Subjects; Genetic Polymorphic CYP3A5
- 2CompletedLast Updated: March 20, 2012Condition(s): Pulmonary Arterial Hypertension
- 3RecruitingLast Updated: March 26, 2012Condition(s): Nonarteritic Anterior Ischemic Optic Neuropathy
- 4CompletedLast Updated: August 22, 2008Condition(s): Erectile Dysfunction; Hypogonadism
- 5Not yet recruitingLast Updated: March 28, 2012Condition(s): Diabetic Nephropathy; Chronic Kidney Disease
- 6Not yet recruitingLast Updated: March 24, 2012Condition(s): Contrast Media Induced Nephropathy
- 7CompletedLast Updated: June 29, 2009Condition(s): Erectile Dysfunction
- 8CompletedLast Updated: April 26, 2012Condition(s): Erectile Dysfunction; Sexual Dysfunction
- 9CompletedLast Updated: September 13, 2010Condition(s): Eisenmenger Syndrome
- 10RecruitingLast Updated: May 8, 2012Condition(s): Anterior Ischemic Optic Neuropathy
- 11Not yet recruitingLast Updated: May 14, 2012Condition(s): Diastolic Heart Failure
- 12RecruitingLast Updated: May 23, 2012Condition(s): Erectile Dysfunction
- 13RecruitingLast Updated: January 28, 2011Condition(s): Raynaud Phenomenon
- 14WithdrawnLast Updated: May 10, 2012Condition(s): Pulmonary Arterial Hypertension
- 15CompletedLast Updated: April 7, 2010Condition(s): Hypertension
- 16RecruitingA Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAIONLast Updated: May 22, 2012Condition(s): Optic Neuropathy, Ischemic
- 17CompletedLast Updated: February 2, 2010Condition(s): Hypogonadism; Erectile Dysfunction
- 18CompletedLast Updated: March 25, 2008Condition(s): Erectile Dysfunction
- 19CompletedLast Updated: April 3, 2012Condition(s): Erectile Dysfunction; Cardiovascular Diseases; Male Urogenital Diseases
- 20CompletedLast Updated: August 17, 2011Condition(s): Anterior Ischemic Optic Neuropathy; Ischemic Optic Neuropathy
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Phosphodiesterase+Type+5+Inhibitors
